GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (OTCPK:IPSEF) » Definitions » Cash Flow for Dividends

Ipsen (IPSEF) Cash Flow for Dividends : $-108 Mil (TTM As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Ipsen Cash Flow for Dividends?

Ipsen's cash flow for dividends for the six months ended in Dec. 2023 was $0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2023 was $-108 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Ipsen's quarterly payment of dividends increased from Dec. 2022 ($0 Mil) to Jun. 2023 ($-108 Mil) but then declined from Jun. 2023 ($-108 Mil) to Dec. 2023 ($0 Mil).

Ipsen's annual payment of dividends increased from Dec. 2021 ($-94 Mil) to Dec. 2022 ($-105 Mil) and increased from Dec. 2022 ($-105 Mil) to Dec. 2023 ($-109 Mil).

Ipsen Cash Flow for Dividends Historical Data

The historical data trend for Ipsen's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Cash Flow for Dividends Chart

Ipsen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -92.44 -101.22 -93.67 -105.19 -108.62

Ipsen Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -104.97 - -107.91 -

Ipsen Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-108 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipsen Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Ipsen's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipsen (IPSEF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (OTCPK:IPSEF) » Definitions » Cash Flow for Dividends
Comparable Companies
XPAR:VETO XPAR:BOI XPAR:EAPI XPAR:AB XPAR:MLCOT XPAR:ALRPD ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX HKSE:03692 TSE:4507 NSE:DIVISLAB BOM:500124
Traded in Other Exchanges
IPSEY:USA 0MH6:UK IPN:France I7G:Germany I7G:Germany
Address
65 Quai Georges Gorse, Billancourt Cedex, Boulogne, FRA, 92100
Website
https://www.ipsen.com
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.